Search

everythinglearnresearchcommunity

for

Search:↓

The monkey's hair loss was due to an autoimmune disease, not genetics.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Certain immune cells in the skin can stop hair from growing.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Using neurohormones to control keratin can lead to new skin disease treatments.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Glycosaminoglycans help heal wounds but aren't yet ready for clinical use.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.